“The CRISPR-Cas System: How It Works In Bacteria And How It Can Be Used To Encounter Antimicrobial Resistant Pathogens” (2023) Journal of Pharmaceutical Negative Results, pp. 3681–3694. doi:10.47750/pnr.2023.14.03.461.